InvestmentSQURPHARMA
SQURPHARMA Approves Factory BMRE Investment
Announcement summary
- What happened
- SQURPHARMA approved a factory BMRE investment.
- Purpose
- BMRE of the company’s factory
- Facility / project
- Factory BMRE
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
The Board of Directors has recommended 105% Cash Dividend for the year ended June 30, 2023. The Board has also approved Tk. 400.00 crore for BMRE, Capital Machineries and Lands for future expansion. Date of AGM: 14.12.2023, Time: 10:00 AM, Venue: Digital Platform. Record Date: 16.11.2023. (cont.)
বাংলা অনুবাদ — BullBD
This is a BullBD translation of the published corporate disclosure.
পরিচালনা পর্ষদ 30 জুন, 2023 সমাপ্ত বছরের জন্য 105% নগদ লভ্যাংশ সুপারিশ করেছে। BMRE, ক্যাপিটাল মেশিনারিজ এবং ভবিষ্যতের সম্প্রসারণের জন্য জমির জন্য 400.00 কোটি। AGM এর তারিখ: 14.12.2023, সময়: 10:00 AM, ভেন্যু: ডিজিটাল প্ল্যাটফর্ম। রেকর্ডের তারিখ: 16.11.2023। (চলবে)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 6535ec799b63f84212ce894e
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.